Redwire Corporation (NYSE: RDW) saw its stock price surge 14.6% to $21.33 in late-morning trading on Thursday, following the announcement of a contract with Astrobiome Space for crop research aboard the International Space Station (ISS). The agreement marks the first commercial deployment of Redwire's Greenhouse system, which enables customers to conduct crop science from laboratory to production in orbit.
The contract, whose financial terms remain undisclosed, has left investors speculating about its potential near-term impact on Redwire's revenue. The company is currently working to convert its record backlog of $498.1 million into recognized revenue, a key factor that analysts are closely monitoring.
Earlier this week, Jefferies analyst Greg Konrad downgraded Redwire from Buy to Hold, citing limited room for near-term gains while the company focuses on transforming its backlog into actual revenue. However, the firm raised its price target on the stock to $24 from $13, reflecting some optimism about the company's long-term prospects.
Redwire's shares hit a session high of $22.75 before settling back slightly, with trading volume reaching approximately 47.8 million shares. The company's market capitalization now stands near $4.13 billion. The stock's performance underscores its growing resemblance to a high-beta space stock rather than a traditional aerospace supplier, as it experiences sharp swings based on sector buzz.
The Greenhouse system, developed by Redwire, is designed to support sustainable life-support systems for off-Earth environments. Under the contract, Astrobiome Space, a Luxembourg-based biotechnology firm, will begin growing test crops on Earth in June ahead of the ISS launch. Vera Mulyani, founder and CEO of Astrobiome, expressed hope that future Mars travelers will still be able to 'taste the Earth' through such innovations.
Redwire's first-quarter results, announced in May, showed revenue of $97.0 million, a 57.9% increase year-over-year. The company reported a book-to-bill ratio of 1.92, indicating that new orders are growing faster than revenue. However, Redwire posted a net loss of $76.5 million for the quarter and an adjusted EBITDA loss of $9.2 million. The company maintained its 2026 revenue guidance of $450 million to $500 million.
The market's reaction to the Astrobiome contract highlights the speculative nature of space-related investments. While the deal represents a strategic win for Redwire, the lack of disclosed financial details raises questions about its materiality. Investors will be watching closely to see whether the contract can meaningfully contribute to turning Redwire's backlog into cash flow.
Other space stocks showed mixed performance on Thursday, with Rocket Lab (RKLB) up 2.5%, Planet Labs (PL) gaining 1.1%, and AST SpaceMobile (ASTS) dropping 2.3%. Redwire's move appeared to be driven more by its own news than by broader sector momentum.
As Redwire continues to trade on optionality—spanning space farming, defense contracts, lunar and orbital systems, and drones—the key test remains whether it can convert its ambitious projects into tangible financial results. The strawberry-growing mission may be a small step, but it could prove to be a significant milestone in demonstrating the commercial viability of space-based agriculture.
